Skip to main content

Table 4 Barriers to dissemination to non-research audiences by work places, research settings, and experience of working in a practice or policy setting

From: Are public health researchers designing for dissemination? Findings from a national survey in China

Barriers

Total (n = 428)

Work place a

Research setting

Experience of working in a practice/policy setting

University/research institution

(n = 147)

CDC at national or regional level (n = 136)

Hospital (n = 124)

Other (n =21 )

Community

Clinical

Yes (n = 270)

No (n = 158)

Yes (n = 257)

No (n = 171)

Yes (n = 174)

No (n = 254)

Organizational level

 Lack of financial resources for dissemination

182 (42.5)

68 (46.3)

57 (41.9)

52 (41.9)

5 (23.8)

115 (44.7)

67 (39.2)

73 (42.0)

109 (42.9)

116 (43.0)

66 (41.8)

 Lack of platforms for dissemination

176 (41.1)

55 (37.4)

62 (45.6)

49 (39.5)

10 (47.6)

110 (42.8)

66 (38.6)

71 (40.8)

105 (41.3)

104 (38.5)

72 (45.6)

 Lack of collaboration mechanisms

139 (32.5)

43 (29.3)

50 (36.8)

38 (30.6)

8 (38.1)

93 (36.2)

46 (26.9)*

50 (28.7)

89 (35.0)

93 (34.4)

46 (29.1)

 Lack of incentives

94 (22.0)

41 (27.9)

27 (19.9)

21 (16.9)

5 (23.8)

67 (26.1)

27 (15.8)*

35 (20.1)

59 (23.2)

58 (21.5)

36 (22.8)

 Lack of relationships with stakeholders

77 (18.0)

27 (18.4)

26 (19.1)

17 (13.7)

7 (33.3)

52 (20.2)

25 (14.6)

18 (10.3)

59 (23.2)*

48 (17.8)

29 (18.4)

 Dissemination activities not in study timelines

67 (15.7)

19 (12.9)

26 (19.1)

18 (14.5)

4 (19.0)

46 (17.9)

21 (12.3)

26 (14.9)

41 (16.1)

47 (17.4)

20 (12.7)

Individual level

 Lack of time

206 (48.1)

74 (50.3)

58 (42.6)

68 (54.8)

6 (28.6)

122 (47.5)

84 (49.1)

95 (54.6)

111 (43.7)*

129 (47.8)

77 (48.7)

 Uncertainty on how to disseminate beyond professional conferences/publications

167 (39.0)

70 (47.6)

39 (28.7)

54 (43.5)*

4 (19.0)

91 (35.4)

76 (44.4)

78 (44.8)

89 (35.0)*

93 (34.4)

74 (46.8)*

 Lack of knowledge and skills to disseminate

115 (26.9)

34 (23.1)

41 (30.1)

36 (29.0)

4 (19.0)

69 (26.8)

46 (26.9)

51 (29.3)

64 (25.2)

79 (29.3)

36 (22.8)

 Uncertainty about audience make-up

96 (22.4)

34 (23.1)

19 (14.0)

41 (33.1)*

2 (9.5)

44 (17.1)

52 (30.4)*

53 (30.5)

43 (16.9)*

49 (18.1)

47 (29.7)*

 Uncertainty about the impact of dissemination

90 (21.0)

21 (14.3)

31 (22.8)

34 (27.4)*

4 (19.0)

52 (20.2)

38 (22.2)

42 (24.1)

48 (18.9)

55 (20.4)

35 (22.2)

 Uncertainty about what to disseminate

66 (15.4)

20 (13.6)

17 (12.5)

28 (22.6)

1 (4.8)

37 (14.4)

29 (17.0)

34 (19.5)

32 (12.6)

35 (13.0)

31 (19.6)

 Hesitation/resistance to disseminate findings from a single study

39 (9.1)

8 (5.4)

20 (14.7)

9 (7.3)*

2 (9.5)

27 (10.5)

12 (7.0)

13 (7.5)

26 (10.2)

25 (9.3)

14 (8.9)

  1. *P < 0.05
  2. Excluded “Other” category when performed Pearson χtest. Abbreviation: CDC Centers for Disease Control and Prevention